Merck buys rights to heart disease drug in latest China deal worth up to $2 billion
On Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
GSK’s Blujepa (gepotidacin) approved by U.S. FDA for treatment of uncomplicated urinary tract infections
On Mar. 25, 2025, GSK announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin)…
Biology | Dentistry | Disease | Environmental | Therapeutics
“Milestones in Fluoride” Cartoon Illustrating the Facts behind Natural Mineral Published
On Mar. 24, 2025, LifeScienceHistory.com published the cartoon “Milestones in Fluoride” illustrating the facts behind the naturally occurring…
Paralysed man stands again after receiving ‘reprogrammed’ stem cells
On Mar. 24, 2025, Hideyuki Okano, a stem-cell scientist at Keio University in Tokyo, and his colleagues announced…
Study uncovers key role of RNA modifications in prostate cancer progression
On Mar. 24, 2025, scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto…
Rice engineer develops new security protocol to protect miniaturized wireless medical implants from cyberthreats
On Mar. 20, 2025, Rice University, electrical and computer engineer Kaiyuan Yang unveiled a first-of-its-kind authentication protocol for…
Scientists solve decades-long Parkinson’s mystery
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
Mallinckrodt and Endo Combine in $6.7 billion Deal to Create Diversified Pharmaceuticals Leader
Mar. 13, 2025, Mallinckrodt and Endo,announced that they had entered into a definitive agreement to combine in a stock…
Marburg virus Outbreak Declared Ended in Tanzania
On Mar. 13, 2025, after two consecutive incubation periods (a total of 42 days) without a new confirmed…
Research Reveals Ways To Keep Emergency Responders Safe In Future Pandemics
On Mar. 11, 2025, researchers from Texas A&M University School of Public Health report findings show significant links…
Australia’s first durable total artificial heart implant Reported successful
On Mar. 11, 2025, researchers at St Vincent’s Hospital Sydney announced the first implant of a BiVACOR Total…
Beam Therapeutics Announces Positive Data in Trial Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
U.S. FDA approves Celltrion’s OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
On Mar. 9, 2025, Celltrion announced the U.S. Food and Drug Administration (FDA) approved OMLYCLO® (omalizumab-igec) as the first and…
Researchers create gel that can self-heal like human skin
On Mar. 7, 2025, a team of researchers from Aalto University and the University of Bayreuth announced that…
Bacterial ‘jumping genes’ can target and control chromosome ends
On Mar. 6, 2025, Cornell researchers announced they have discovered a new mechanism that genes use to survive…
Scientists identify genes that make humans and Labradors more likely to become obese
On Mar. 6, 2025, researchers at the University of Cambridge announced they have discovered genes linked to obesity…
Diagnostics | Disease | FDA | Medical Device | Non-Profit Research | Ophthalmogy | Rare Disease | Therapeutics
FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease
On Mar. 6, 2025, the U.S. Food and Drug Administration (FDA) announced the approval of ENCELTO (revakinagenetaroretcel-lwey), a…
Novel Stem Cell Therapy Repairs Irreversible Corneal Damage in Clinical Trial
On Mar. 4, 2025, researchers at a Mass Eye and Ear Institute-led trial announced taking stem cells from…
More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
World first procedure fixes lamb’s leaky heart
On Mar. 3, 2025, researchers from Oregon State University (OSU) announced the world’s first procedure successfully fixes lamb’s…
Biotechnology | Disease | FDA | Medicine | Neurology | Therapeutics
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
On Mar. 3, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase),…
New methods reveal cancer mechanism in ancient genes
On Mar. 3, 2025, researchers at Fred Hutch Cancer Center announced they have discovered an overlooked mechanism driving…
Biotechnology | Diagnostics | Disease | FDA | Therapeutics
FDA approves ODACTRA® for the treatment of house dust mite allergy in young children
On Feb. 27, 2025, ALK announced that the U.S. Food and Drug Administration (FDA) has approved ALK’s ODACTRA®…
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
Breast cancer is on the rise: data reveal drastic gap in survival rates
On Feb. 24, 2025, breast cancer is the most common cancer in women worldwide, but survival chances vary…
FDA declares Wegovy® and Ozempic® shortage is over and Supply now exceeds nationwide demand
On Feb. 21, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has determined the…
New hybrid custom-designed Microscope Can Image Full 3D Orientation & Position of Molecules in Cells
On Feb. 21, 2025, a team of researchers from the Marine Biological Laboratory (MBL) announced a hybrid custom-designed…
Child ADHD risk linked to mother’s use of acetaminophen
On Feb. 20, 2025, researchers from the University of Washington and Seattle Children’s Research Institute announced findings from…
UVA Heath Discovery Reveals Potential Key to Reversing Hair Loss
On Feb. 19, 2025, researchers led by University of Virginia’s (UVA) Lu Q. Le, MD, PhD, announced they…
CPRIT awards $68 million in research grants to Texas institutions
On Feb. 19, 2025, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…